Steroid studies in relation to cancer are becoming increasingly important and evidence slowly grows to support the view that specific steroid endocrine disturbances are associated with some types of cancer. The Guys Hospital-Imperial Cancer Research Fund group have reviewed their experience in selecting patients with breast cancer for endocrine surgery on the basis of their steroid excretion pattern (Atkins et al., 1968) and an extension of the work is aimed at selecting a breast cancer prone population (Bulbrook and Hayward, 1967) . Other workers have found abnormal steroid excretion in patients with carcinoma of the uterus (de Waard et al., 1968) . Whether health screening using steroid excretion is likely to become important is debatable, but the amount of work involved with present techniques would make this a considerable undertaking. using work-simplification techniques and Brown et al. (1968) have described a useful automatic extractor which is designed for the assay of urinary oestrogens, but which has obvious applications to other biochemical procedures.
Steroid binding
There is little doubt that the discovery of specific steroid binding proteins and their application to steroid assay is one of the most important advances in this field for many years. By setting up a competition for binding protein, between radio-labelled steroid and the steroid in the test sample, amounts in the range 10-8 to 10-10g or less can be assayed (Murphy, 1967) . In principle the technique resembles the radio-immunoassay of protein hormones, and like the latter, requires special equipment for isotope counting and some degree of skill. For certain steroid hormones it offers high sensitivity and specificity and compares favourably with any other available method.
The introduction of simple fluorimetric methods for the assay of plasma cortisol has considerably altered the clinical approach to the investigation of patients with pituitary or adrenal disease. There 155
Group analysis
Paper read at Southern England and South Wales Resional McctinS. London, March, 1969. Group methods of analysis (in the sense that the methods determine a group of metabolites) have long been used for 17-hydroxycorticosteroids and 17-oxosteroids, and none too early perhaps, group methods for oestrogens are now being developed which do not require the separation and measurement of individual metabolites. At present the most important application is in monitoring foetalplacental function and although there is as yet insufficient experience available to assess fully the clinical value of this assay, it already has strong advocates (Oakey et al., 1968) .
The problem of providing large numbers of steroid assays reliably and rapidly is a growing one and attempts have been made to produce automated analytical methods. Automated techniques for pregnancy 'oestriol' (Conail and Muir, 1968) , urinary 17-hydroxycorticosteroids (Caisey and Child, 1967) and plasma cortisol (Townsend and James, 1968) have appeared, but they need a large steroid workload to justify the heavy capital investment involved. In any event, steroid automation is still at an early stage of development and most existing methods leave much to be desired in terms of mechanical simplicity and reliability. On the other hand, much can be done to improve analytical reliability by An attempt will be made to review briefly those aspects of steroid hormones which appear to be of immediate or possibly of future interest to the clinical biochemist.
As in any field, the development of methods is of prime importance and since steroid analytical methods are generally rather complex there is a continuing trend towards simplification and improvement. The M.R.C. Clinical Endocrinology Committee therefore at intervals investigates and publishes analytical methods for steroids, and recently they have carried out an appraisal of a method for urinary 17-hydroxycorticosteroids (Gray et al., 1969) . The published performance data are useful to the clinical biochemist who can compare results in his own laboratory, and can ascertain what degree of reliability he can expect from the method.
is now a strong tendency to replace methods employing urinary steroid excretion with those based upon plasma cortisol determinations and adrenal function tests using plasma assays before and after ACfH administration are well established and widely used. As an alternative to the use of metyrapone for the investigation of pituitary function, pyrogen, hypoglycaernia and lysine vasopressin have been employed in conjunction with plasma determinations. In the investigation of suspected Cushing's syndrome the study of the diurnal rhythm of cortisol secretion and the effect of dexamethasone are most easily studied by plasma assays and Bea.rdwell et al. (1968) have indicated the value of urinary cortisol estimations in the diagnosis of this condition. All these tests have been considered at a recent symposium (James and Landon, 1968a) and reviewed elsewhere (James and Landon, 1968b) .
In this brief review, it has only been possible to cover certain selected areas of this field, but it is clear that steroid hormones continue to occupy an area both in research and diagnosis, which is of considerable importance and interest to the clinical biochemist.
